Conversely, the correlation of pharmacological linkage, and IgA-IgG4 in the BD group was increased only in the patients who received immunomodulatory therapy (BD-C, BD-I and BD-C&I) (Fig. 2f). Here, CD79A is linked to Behcet disease.